Is there a cure for Long Covid? This honest, evidence-based guide explains why there is currently no established cure, how recovery differs between people, what treatments may help symptoms, and why hope must be balanced with evidence.
Tag: immune dysregulation
Long COVID and the Immune System: Why It Can Be Both Overactive and Underactive
Long Covid presents a complex immune dysfunction characterized by simultaneous hyperactivity and hypoactivity, leading to inflammation, immune exhaustion, autoimmunity, and reactivation of latent viruses. Patients face chronic immune dysregulation, resulting in persistent fatigue and increased vulnerability to infections. Understanding these interconnected mechanisms is crucial for effective management and treatment.
Immunotherapy for Long COVID: IVIG, Rituximab and Monoclonal Antibodies Explained
IVIG, rituximab and monoclonal antibodies are increasingly discussed as possible Long Covid treatments. Here is what the evidence shows, why access remains difficult and what researchers still do not know.
Decoding ME/CFS: Key Genetic Findings Explained
The DecodeME study identified eight genetic regions associated with ME/CFS, offering new clues about the immune and nervous systems. Here's what the findings mean, what newer 2026 research adds and why there is still no diagnostic genetic test or targeted cure.
Can Monoclonal Antibodies Help Long COVID? What the Latest Research Really Shows
Can monoclonal antibodies help Long COVID? Learn how these targeted medicines work, why researchers are studying Sipavibart, Pemgarda and Evusheld, and what current evidence says about viral persistence, NHS access and future treatments.
Role of Galectin-3 in Long COVID Symptoms
Galectin-3 is an inflammatory protein being investigated as a possible contributor to Long COVID. Learn how it may interact with microclots, inflammation and immune dysfunction, and why researchers see it as a promising but still experimental treatment target.
